# Expanded Noninvasive Genomic Medical Assessment: The Enigma Study

> **NCT02787486** · — · COMPLETED · sponsor: **Progenity, Inc.** · enrollment: 760 (actual)

## Conditions studied

- Down Syndrome
- Edwards Syndrome
- Patau Syndrome
- Klinefelter Syndrome
- Turner Syndrome
- DiGeorge Syndrome
- Chromosome Deletion
- Aneuploidy

## Interventions

- **OTHER:** Blood sampling for Laboratory Developed Test (LDT) analysis

## Key facts

- **NCT ID:** NCT02787486
- **Lead sponsor:** Progenity, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 760 (ACTUAL)
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02787486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02787486, "Expanded Noninvasive Genomic Medical Assessment: The Enigma Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02787486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*